AbbVie
ABBV
#26
Rank
โ‚น35.895 T
Marketcap
โ‚น20,310
Share price
-1.15%
Change (1 day)
39.89%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น6.175 Trillion

According to AbbVie's latest financial reports the company's total debt is โ‚น6.175 Trillion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น5.760 T16.51%
2023-12-31โ‚น4.943 T-5.58%
2022-12-31โ‚น5.235 T-8.27%
2021-12-31โ‚น5.707 T-9.31%
2020-12-31โ‚น6.293 T32.26%
2019-12-31โ‚น4.758 T68.82%
2018-12-31โ‚น2.818 T18.13%
2017-12-31โ‚น2.385 T-4.7%
2016-12-31โ‚น2.503 T18.95%
2015-12-31โ‚น2.104 T121.73%
2014-12-31โ‚น949.21 B4.36%
2013-12-31โ‚น909.58 B6%
2012-12-31โ‚น858.08 B33693.67%
2011-12-31โ‚น2.53 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚น5.466 T-11.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.585 T-25.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.818 T-38.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น4.903 T-20.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.240 T-63.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น592.03 B-90.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น2.143 T-65.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚น2.931 T-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น38.48 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA